Mild surfection of neural cells, especially motoneurons, in primary culture and cell lines.

Unité 583 de l'INSERM, Institut des Neurosciences de Montpellier Hôpital Saint-Eloi, 80, rue Augustin-Fliche FR-34091 Montpellier, Cedex 05, France.
Experimental Neurology (Impact Factor: 4.62). 04/2007; 204(1):118-30. DOI: 10.1016/j.expneurol.2006.09.027
Source: PubMed

ABSTRACT Of all cell types, motoneurons (MNs), are possibly the most difficult to maintain in culture, since their development and survival is conditioned by many factors that are still in the course of identification. This may also be the reason why they are difficult to transfect. We succeed to transfect these fragile cells with lipoplex [DOTAP:PC (10:1)-pGFP]-precoated coverslips. Here, we report that this original method, also termed 'surfection' does not perturbate MN development and survival while giving important transfection yield (15%). Lipofectamine 2000 and other well-known auxiliary lipids (DOPE, Chol) give lower surfection yields. The use of (DOTAP:PC)-based lipid vector also can be extended to several neural and non-neural cell lines with appreciable transfection yield such as a glial cell line (GCL) derived from rat spinal cord (65%), HeLa S3 (60%), COS-7 (30%) and HEK 293 cells (20%). The efficiency of DOTAP:PC (10:1) and Lipofectamine 2000 vectors in our surfection method are compared on standard HeLa S3 cell lines. Lipofectamine 2000 (72%) is slightly better than DOTAP:PC (10:1) (60%). However, the surfection method improved the efficiency of Lipofectamine 2000 itself (72%) as compared to the classical (62%) approach. In summary we have developed an original standard surfection protocol for both MN primary cultures and cell lines, thus simplifying laboratory practice; moreover, Lipofectamine 2000 used in this surfection method is more efficient for the cell lines than the manufacturer-recommended method. We emphasize that our method particularly spares fragile cells like MNs from injure and therefore, might be applied to other fragile cell type in primary cultures.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Spinal cord injury (SCI) normally results in life-long disabilities and a broad range of secondary complications. Advances in therapeutic delivery during the past few decades offer hope for such victims. However, the limited functional improvement shown in in vivo studies hinders effective therapeutic application in clinical practice. Recent studies showed that gene vectors can transfect cells present in the lesion of an injured spinal cord (endogenous cells) and thereby produce therapeutic molecules with long-lasting biological effects that promote neural tissue regeneration. In this article we review recent advances in non-viral gene delivery into neural cells and their use for gene therapy in SCI.
    Drug discovery today 05/2012; 17(17-18):998-1005. · 6.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: As one of the nine hereditary neurodegenerative polyQ disorders, spinal and bulbar muscular atrophy (SBMA) results from a polyQ tract expansion in androgen receptor (AR). Although protein aggregates are the pathological hallmark of many neurodegenerative diseases, their direct role in the neurodegeneration is more and more questioned. To determine the early molecular mechanisms causing motor neuron degeneration in SBMA, we established an in vitro system based on the tetracycline-inducible expression of normal (AR20Q), the mutated, 51 glutamine-extended (AR51Q), or polyQ-deleted (AR0Q) AR in NSC34, a motor neuron-like cell line lacking endogenous AR. Although no intracellular aggregates were formed, the expression of the AR51Q leads to a loss of function characterized by reduced neurite outgrowth and to a toxic gain of function resulting in decreased cell viability. In this study, we show that both AR20Q and AR51Q are recruited to lipid rafts in response to testosterone stimulation. However, whereas testosterone induces the activation of the c-jun N-terminal kinase/c-jun pathway via membrane-associated AR20Q, it does not so in NSC34 expressing AR51Q. Phosphorylation of c-jun N-terminal kinase plays a crucial role in AR20Q-dependent survival and differentiation of NSC34. Moreover, c-jun protein levels decrease more slowly in AR20Q- than in AR51Q-expressing NSC34 cells. This is due to a rapid and transient inhibition of glycogen synthase kinase 3α occurring in a phosphatidylinositol 3-kinase-independent manner. Our results demonstrate that the deregulation of nongenomic AR signaling may be involved in SBMA establishment, opening new therapeutic perspectives.
    Molecular Endocrinology 05/2012; 26(7):1102-16. · 4.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: While efficient methods for cell line transfection are well described, for primary neurons a high-yield method different from those relying on viral vectors is lacking. Viral vector-based primary neuronal infection has several drawbacks, including complexity of vector preparation, safety concerns and the generation of immune and inflammatory responses, when used in vivo. This article will cover the different approaches that are being used to efficiently deliver genetic material (both DNA and small interfering RNA) to neuronal tissue using nonviral vectors, including the use of cationic lipids, polyethylenimine derivatives, dendrimers, carbon nanotubes and the combination of carbon-made nanoparticles with dendrimers. The effectiveness, both in vivo and in vitro, of the different methods to deliver genetic material to neural tissue is discussed.
    Nanomedicine 10/2010; 5(8):1219-36. · 5.26 Impact Factor